The benign prostate hyperplasia (BPH) or benign prostate enlargement (BPE), is a disease common in older men. Approximately 85% of all males over the age of 60 are affected by BPH. The decision about the necessity and the type of the treatment performed depends on the symptoms of the patient, and an evidenced bladder dysfunction.
According to the latest findings, frequent urinating or urinating during sleep, and an uncontrollable urge to urinate, interfere more severely with a patient’s quality of life than the so-called obstructive symptoms, e.g., urethra stream volume, occasional dribbling after urination, or difficulty to start a urine stream.
Generally, there are two treatment options. Firstly, the treatment with medication (pharmacotherapy) and secondly, surgery.
In cases were the above described biomedical measures are not resulting in the desired success, generally an endoscope or surgical procedure is necessary for the relief of urethral flow obstruction. Aside from the today only rarely required open prostatectomy, transurethral resection of the prostate (TURP), the recent TURiS-Resection and vaporization in which obstructing tissue is removed one piece at a time from the inside of the prostate gland, and the Laser prostatectomy that uses beams of light to destroy prostate tissue, which has the advantage that there is less bleeding. The West German Prostate Center offers as one of the few centers in Germany the Greenlight laser transurethral resection as well as the highly modern diode laser procedure. The latter method is especially suited for the patient with a large prostate.
- Ten misconceptions about the treatment of prostate cancer
- ESTRO: Brachytherapy achieves excellent results
- Second Tumar after Prostate Cancer Therapy?
- Prostate Cancer is operated too often
- Fewer complications after laser therapy
- Prostate cancer: Spacer Gel protects against radiation damages
- Dr. Neubauer nominated again best urologist in Germany
- Prostate Cancer - Surgery often not justified